Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Crohn's Disease Health Center

Font Size

FDA OKs Tysabri for Crohn's Disease

Tysabri, a Multiple Sclerosis Drug, Carries 'Black Box' Warning About Brain Disease Risk
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 14, 2008 -- The FDA today approved the multiple sclerosis drug Tysabri for the treatment of Crohn's disease.

Tysabri may be used to treat patients who have moderate to severe Crohn's disease with evidence of inflammation who don't adequately respond to or can't tolerate other Crohn's disease therapies.

Tysabri, a biologic drug given by health care professionals at infusion centers, carries a "black box" warning (the FDA's sternest warning) about the risk of a rare, serious brain disease called progressive multifocal leukoencephalopathy (PML).

Tysabri was taken off the market in February 2005 because of that risk. The drug returned to the market in June 2006 under a restricted distribution program after no new cases of PML were seen in patients who had taken Tysabri prior to the drug's suspension.

Crohn's patients who take Tysabri -- and doctors, infusion centers, and pharmacies that provide Tysabri -- must enroll in the restricted Crohn's Disease Tysabri Outreach Unified Commitment to Health, or CD TOUCH, prescribing program.

"With the addition of Tysabri to the treatment options for sufferers of Crohn's disease, we make an important step in the armamentarium for treatment, but one that carries serious risks," Joyce Korvick, MD, deputy director of the FDA's division of gastroenterology products, told reporters. "Health care providers must carefully monitor patients for these risks."

Korvick also confirmed that no new cases of PML have been reported in Tysabri users since the drug returned to market. Tysabri's makers, Biogen Idec and Elan, will conduct long-term surveillance studies of Tysabri, including monitoring PML cases, says Korvick.

Tysabri Time Line

Here's a quick recap of Tysabri's history:

November 2004: The FDA first approves Tysabri for the treatment of multiple sclerosis.

February 2005: Tysabri's makers, the drug companies Biogen-Idec and Elan, take Tysabri off the market after three people out of about 3,000 patients taking Tysabri in clinical trials developed a rare, serious brain infection called progressive multifocal leukoencephalopathy (PML). Two of those patients died.

March 2006: Researchers report no new cases of PML in patients who took Tysabri before the drug's suspension. An FDA panel unanimously recommends returning Tysabri to the market.

June 2006: The FDA allowed Tysabri back on the market under a restricted distribution program to treat relapsing forms of multiple sclerosis.

Today on WebMD

butter curls
Foods to avoid.
woman with pains in abdomen
Get personalized tips.
woman in restaurant
Tips for staying active.
Woman suffering from IBD
Learn about Crohn’s, colitis, and more.
Treatment Options For Crohns Disease
butter curls
crohns disease healthcheck
capsules in hand
Trigger Foods To Avoid With Crohns
Exercising When You Have A GI Disorder
Newly Diagnosed With Crohns Steps To Take
When Surgery Might Be Required For Crohns